Ownership history in Verity & Verity, LLC Β· 44 quarters on record
This page tracks every 13F SEC filing in which Verity & Verity, LLC reported a position in Abbvie Inc Equity (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Verity & Verity, LLC outperformed the S&P 500 by +7.1% annually on this ABBV position. Timing score: 59% (23/39 decisions correct). Average cost basis: $87.53. Maximum drawdown during holding period: β20.3%.
π₯ Exceptional β beat the S&P 500 by 7.1% per year on this position.
42 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
23 of 39 add/trim decisions correct
Best entry: $31.80 (2014 Q1) Β· Worst: $228.05 (2025 Q3)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
34 adds Β· 7 trims. Bought during 13 of 16 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π Verity & Verity, LLC has been actively increasing its ABBV allocation β a bullish signal from insiders.
Currently 3.1% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size